Global advisory firm Stout Risius Ross added John Calcagnini as a managing director in the Investment Banking group’s healthcare industry practice.

Prior to joining Stout, Calcagnini was head of Healthcare at CRT Capital Group and head of Medical Device Investment Banking in the healthcare practice at CIBC World Markets/Oppenheimer.

Calcagnini, who will be based in Los Angeles, brings extensive experience with mergers, acquisitions, divestitures, joint ventures, restructurings, and equity and debt financings, and he has successfully executed more than 40 transactions in the healthcare industry.

“Stout is known for deep industry expertise, and I’m thrilled to add even greater depth to our team,” said Nick Jachim, managing director and head of Investment Banking at Stout. “John has worked with some of the most dynamic companies across a variety of sectors, including biotech, specialty pharmaceuticals, and medical devices. We can’t wait to leverage his insights to create value for new clients in the healthcare arena.”

Stout’s Investment Banking group provides mergers and acquisitions advice, private capital raising and other financial advisory services for private equity portfolio companies, closely held or family-owned businesses, and divisions of large corporate parents.